Cargando…
No association between use of angiotensin‐converting enzyme inhibitors or angiotensin II receptor blockers prior to hospital admission and clinical course of COVID‐19 in the COvid MEdicaTion (COMET) study
Since the outbreak of SARS‐CoV‐2, also known as COVID‐19, conflicting theories have circulated on the influence of angiotensin‐converting enzyme inhibitors (ACEi) and angiotensin II receptor blockers (ARB) on incidence and clinical course of COVID‐19, but data are scarce. The COvid MEdicaTion (COMET...
Autores principales: | Sablerolles, Roos S. G., Hogenhuis, Freija E. F., Lafeber, Melvin, van de Loo, Bob P. A., Borgsteede, Sander D., Boersma, Eric, Versmissen, Jorie, van der Kuy, Hugo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8014637/ https://www.ncbi.nlm.nih.gov/pubmed/33507556 http://dx.doi.org/10.1111/bcp.14751 |
Ejemplares similares
-
COvid MEdicaTion (COMET) study: protocol for a cohort study
por: Sablerolles, Roos S G, et al.
Publicado: (2020) -
Association between Clinical Frailty Scale score and hospital mortality in adult patients with COVID-19 (COMET): an international, multicentre, retrospective, observational cohort study
por: Sablerolles, Roos S G, et al.
Publicado: (2021) -
Effect of renal denervation on catecholamines and the
renin–angiotensin–aldosterone system
por: Feyz, Lida, et al.
Publicado: (2020) -
Angiotensin receptor blockers and COVID-19
por: Saavedra, Juan M.
Publicado: (2020) -
Effects of angiotensin receptor blockers and angiotensin-converting enzyme inhibitors on COVID-19
por: Li, Xiao-Long, et al.
Publicado: (2021)